Loading
Latest filing published 09 Apr 2026 for Adial Pharmaceuticals, INC..
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Tony Goodman appears in our data through filings on Adial Pharmaceuticals, Inc. shares, published by SEC (Form 4). In total, 2 filings cover trades dated from 31 July 2018 to 7 April 2026.
The open-market record is one-sided, with 1 purchase and not one sale. No amount is published for 1 filing, which the totals therefore leave out. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 1 share grant.
The record was last updated on 9 April 2026 with a share grant in Adial Pharmaceuticals, Inc. The last insider purchase was made public on 2 August 2018, 3,005 days ago. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations